----item----
version: 1
id: {C959D8F0-4621-4DEF-9396-792E8F0CB27D}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/1995/07/17/Abbotts second quarter hospitals sales rise 69
parent: {22C5F4C9-3E20-450E-A15B-315DB823AD7A}
name: Abbotts second quarter hospitals sales rise 69
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: d1450dc3-0542-4867-ab75-8b75a2924b1e

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 340

<p>Sales growth at <strong>[C#198600101:Abbott]</strong>'s hospital and laboratory division has increased to 6.9% in the second quarter compared with a year earlier from the 5.8% reported for the first quarter of the year. US sales of hospital and laboratory products accounted for $589 million and international sales for $518 million.</p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 49

Abbott's second quarter hospitals sales rise 6.9%
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 998

<p>Sales growth at <strong>[C#198600101:Abbott]</strong>'s hospital and laboratory division has increased to 6.9% in the second quarter compared with a year earlier from the 5.8% reported for the first quarter of the year. US sales of hospital and laboratory products accounted for $589 million and international sales for $518 million.</p><pre>Abbott's results 2nd Change 1st Change quarter from '94 half from '94 Hospital & laboratory 1,107 6.9% 2,156 6.4% Pharmaceutical & nutritional 1,394 19.2% 2,869 19.9% Total sales 2,500 13.4% 5,025 13.7% Net income 424 12.6% 841 13.3% (ended June 30th)</pre><p>During the second quarter, Abbott launched LCx, its DNA probe technology system, in most parts of the world excluding the US, France and Japan. In conjunction with LCx, the company introduced its first DNA amplification test, a urine-based test for Chlamydia trachomatis for both men and women (see Clinica No 657, p 1). An LCx test for gonorrhoea will follow later this year, Abbott says.</p>
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 116

{B2967A9C-ABDA-4628-A672-9EDDCD142AEA}|{FC1DA89F-D8A0-415D-99B6-86FF397EC709}|{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 46

Abbotts second quarter hospitals sales rise 69
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

19950717T000000
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

19950717T000000
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

19950717T000000
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT053525
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 49

Abbott's second quarter hospitals sales rise 6.9%
----field----
field: {53288D3D-66D7-4ACE-B3E4-D7D02B1F3672}
name: Referenced Companies
key: referenced companies
content-length: 9

198600101
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 4

News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

255334
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T184527Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

d1450dc3-0542-4867-ab75-8b75a2924b1e
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T184527Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
